Business
British regulators asked to assess AstraZeneca-Oxford COVID-19 vaccine, as new trial looks into lower dosage – ABC News
The British Government formally asks its medicines regulator to assess whether the AstraZeneca-Oxford COVID-19 vaccine should be authorised for use as the vaccine’s…
The British Government has formally asked its medicines regulator to assess whether a coronavirus vaccine developed by drug company AstraZeneca and Oxford University should be authorised for use.
It comes as AstraZeneca said it plans to conduct a new global clinical trial to assess the vaccine’s efficacy.
UK Health Secretary Matt Hancock said he had asked the Medicines and Healthcare Products Regulatory Agency to determine whether the vaccine “meets rigorous safety standards.”
Here’s the latest…
-
Business23 hours agoHow to turn a $50,000 ASX share portfolio into a passive income machine
-
General22 hours agoMortgage belt hoping lower inflation heralds rate cut
-
Business14 hours agoIf I could only own 1 ASX retailer for the next 5 years it would be this one
-
Noosa News17 hours agoTownsville hosts inaugural roadshow – Proctor